Hospital operator Tenet Healthcare (NYSE: THC) met Wall Street’s revenue expectations in Q1 CY2026, with sales up 2.8% year on year to $5.37 billion. On the other hand, the company’s full-year revenue guidance of $21.9 billion at the midpoint came in 0.5% below analysts’ estimates. Its non-GAAP profit of $4.82 per share was 15.7% above analysts’ consensus estimates.

Is now the time to buy Tenet Healthcare? Find out by accessing our full research report, it’s free.

Company Overview

With a network spanning nine states and serving primarily urban and suburban communities, Tenet Healthcare (NYSE: THC) operates a nationwide network of hospitals, ambulatory surgery centers, and outpatient facilities providing acute care and specialty healthcare services.

Revenue Growth

Reviewing a company’s long-term sales performance reveals insights into its quality. Any business can experience short-term success, but top-performing ones enjoy sustained growth for years. Over the last five years, Tenet Healthcare grew its sales at a tepid 3.7% compounded annual growth rate. This wasn’t a great result compared to the rest of the healthcare sector, but there are still things to like about Tenet Healthcare.

We at StockStory place the most emphasis on long-term growth, but within healthcare, a half-decade historical view may miss recent innovations or disruptive industry trends. Tenet Healthcare’s recent performance shows its demand has slowed as its annualized revenue growth of 1.3% over the last two years was below its five-year trend. We’re wary when companies in the sector see decelerations in revenue growth, as it could signal changing consumer tastes aided by low switching costs.

We can dig further into the company’s revenue dynamics by analyzing its same-store sales, which show how much revenue its established locations generate. Over the last two years, Tenet Healthcare’s same-store sales averaged 1.7% year-on-year growth. This number doesn’t surprise us as it’s in line with its revenue growth.

This quarter, Tenet Healthcare grew its revenue by 2.8% year on year, and its $5.37 billion of revenue was in line with Wall Street’s estimates.

Looking ahead, sell-side analysts expect revenue to grow 2.9% over the next 12 months. While this projection indicates its newer products and services will catalyze better top-line performance, it is still below the sector average. At least the company is tracking well in other measures of financial health.

ONE MORE THING: 3 Hidden Platforms Growing 3X Faster than Amazon, Google, and PayPal. Amazon, Google, and Meta all followed the same playbook: Dominate an ignored market. Build an unbeatable moat. Scale until you’re unstoppable.

These three platforms are running that exact playbook right now. The early investors in Amazon made fortunes. The early investors in these could do the same. Get All 3 Stocks Here for FREE.

Adjusted Operating Margin

Adjusted operating margin is an important measure of profitability as it shows the portion of revenue left after accounting for all core expenses – everything from the cost of goods sold to advertising and wages. It’s also useful for comparing profitability across companies because it excludes non-recurring expenses, interest on debt, and taxes.

Tenet Healthcare has managed its cost base well over the last five years. It demonstrated solid profitability for a healthcare business, producing an average adjusted operating margin of 15.3%.

Analyzing the trend in its profitability, Tenet Healthcare’s adjusted operating margin rose by 4.8 percentage points over the last five years, as its sales growth gave it operating leverage. The company’s two-year trajectory shows its performance was mostly driven by its recent improvements.

In Q1, Tenet Healthcare generated an adjusted operating margin profit margin of 24.6%, up 6.3 percentage points year on year. This increase was a welcome development and shows it was more efficient.

Earnings Per Share

We track the long-term change in earnings per share (EPS) for the same reason as long-term revenue growth. Compared to revenue, however, EPS highlights whether a company’s growth is profitable.

Tenet Healthcare’s EPS grew at 16.8% compounded annual growth rate over the last five years, higher than its 3.7% annualized revenue growth. This tells us the company became more profitable on a per-share basis as it expanded.

Diving into Tenet Healthcare’s quality of earnings can give us a better understanding of its performance. As we mentioned earlier, Tenet Healthcare’s adjusted operating margin expanded by 4.8 percentage points over the last five years. On top of that, its share count shrank by 18.9%. These are positive signs for shareholders because improving profitability and share buybacks turbocharge EPS growth relative to revenue growth.

In Q1, Tenet Healthcare reported adjusted EPS of $4.82, up from $4.36 in the same quarter last year. This print easily cleared analysts’ estimates, and shareholders should be content with the results. Over the next 12 months, Wall Street expects Tenet Healthcare’s full-year EPS of $17.24 to stay about the same.

Key Takeaways from Tenet Healthcare’s Q1 Results

It was good to see Tenet Healthcare beat analysts’ EPS expectations this quarter. We were also happy its full-year EPS guidance outperformed Wall Street’s estimates. On the other hand, its revenue was just in line and its full-year revenue guidance fell slightly short of Wall Street’s estimates. Overall, this print was mixed. Investors were likely hoping for more, and shares traded down 2.3% to $175.99 immediately after reporting.

Is Tenet Healthcare an attractive investment opportunity right now? If you’re making that decision, you should consider the bigger picture of valuation, business qualities, as well as the latest earnings. We cover that in our actionable full research report which you can read here (it’s free).